Biological reconstruction: the use of a fibular flap in the treatment of diaphyseal defects in pediatric patients with malignant bone tumors

The use of vascularized fibula flaps for the reconstruction of diaphyseal defects after resection of malignant bone tumors has a long history and has proved to be an effective method. A unique advantage of this technique is that instead of massive titanium endoprosthesis the patient's own bone is used for repair. Between September 2013 and September 2021, reconstruction using a vascularized fibula flap was performed in 32 patients admitted to the Department of Oncology and Pediatric Surgery of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. The median follow-up was 3.2 years. Complications were analyzed according to the Henderson classification. Despite a high rate of complications (37.5%), excellent and good functional results were achieved in 87.5% cases. To evaluate the functional outcomes after surgical treatment, we used the international MusculoSkeletal Tumor Society Score (MSTS). It is important to note that after this type of surgery, there are no restrictions in walking (in terms of distance) and practicing sports activities that are usually not recommended after endoprosthetic reconstruction, such as doing barbell leg exercises, skiing, running, and rock climbing. The study was approved by the Independent Ethics Committee and Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation.

Authors

Institutions

Publication Details

Journal
Pediatric Hematology/Oncology and Immunopathology
Published
2024-10-13
DOI
https://doi.org/10.24287/1726-1708-2024-23-3-36-43
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biological reconstruction: the use of a fibular flap in the treatment of diaphyseal defects in pediatric patients with malignant bone tumors

A. Yu. Artemov, Николай Сергеевич Грачев, Alexander V. Alexandrov, N. A. Bolshakov et al.
Pediatric Hematology/Oncology and Immunopathology
Sarcoma Diagnosis and Treatment
article

Biological reconstruction: the use of a fibular flap in the treatment of diaphyseal defects in pediatric patients with malignant bone tumors

A. Yu. Artemov, Николай Сергеевич Грачев, Alexander V. Alexandrov, N. A. Bolshakov, M. V. Tikhonova, A. M. Vorochay, В. В. Рыбченок, A. S. Slinin
article en

Abstract

The use of vascularized fibula flaps for the reconstruction of diaphyseal defects after resection of malignant bone tumors has a long history and has proved to be an effective method. A unique advantage of this technique is that instead of massive titanium endoprosthesis the patient's own bone is used for repair. Between September 2013 and September 2021, reconstruction using a vascularized fibula flap was performed in 32 patients admitted to the Department of Oncology and Pediatric Surgery of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. The median follow-up was 3.2 years. Complications were analyzed according to the Henderson classification. Despite a high rate of complications (37.5%), excellent and good functional results were achieved in 87.5% cases. To evaluate the functional outcomes after surgical treatment, we used the international MusculoSkeletal Tumor Society Score (MSTS). It is important to note that after this type of surgery, there are no restrictions in walking (in terms of distance) and practicing sports activities that are usually not recommended after endoprosthetic reconstruction, such as doing barbell leg exercises, skiing, running, and rock climbing. The study was approved by the Independent Ethics Committee and Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation.

Pediatric Hematology/Oncology and ImmunopathologyVol. 23(3)
Pirogov Russian National Research Medical University (RU), Ministry of Health of the Russian Federation (RU), Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology (RU), City Clinical Hospital No15 named. O. M. Filatova (RU)
Good health and well-being
Openalex Percentile: Top 67%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.